Basic GLP-1 Blood Test Panel
The Basic GLP-1 Blood Test Panel provides a comprehensive baseline for metabolic health by evaluating glucose control, insulin levels, lipids, thyroid function, organ health, and blood cell markers. Designed to support GLP-1–related monitoring and preventive care, this panel delivers clinically relevant insights that help patients and healthcare providers understand metabolic trends, assess risk, and track changes over time.
- $129
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: A1c with eAG, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hgb A1c
Eag (Mg/Dl)
Eag (Mmol/L)
Hemoglobin A1c
Also known as: Insulin (fasting)
Insulin
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
The Basic GLP-1 Blood Test Panel panel contains 6 tests with 65 biomarkers .
The Basic GLP-1 Blood Test Panel is a foundational laboratory assessment designed to evaluate key metabolic, glycemic, lipid, thyroid, and general health markers commonly reviewed before and during GLP-1–related metabolic care. While GLP-1 medications and interventions primarily influence blood sugar regulation, appetite signaling, and insulin sensitivity, safe and effective monitoring requires a broader clinical picture. This panel delivers that context by combining hematologic, metabolic, endocrine, and cardiovascular-related biomarkers into a single, comprehensive baseline.
Rather than focusing on a single hormone or pathway, the panel examines how glucose control, insulin dynamics, lipid metabolism, liver and kidney function, thyroid activity, and overall blood health intersect. These systems are closely connected in metabolic health and weight regulation, and changes in one area often influence others. Establishing a clear baseline allows clinicians and patients to interpret future changes accurately and detect early shifts that may require attention.
The panel includes a Complete Blood Count (CBC) with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Hemoglobin A1c with estimated average glucose (eAG), Insulin, Lipid Panel, and Thyroid-Stimulating Hormone (TSH). Together, these tests provide objective data that supports informed clinical decision-making, ongoing monitoring, and long-term metabolic health planning.
When and Why Someone Would Order This Panel
Establishing a Metabolic Baseline
One of the most common reasons to order the Basic GLP-1 Blood Test Panel is to establish a metabolic baseline before initiating or adjusting a GLP-1–based treatment plan. Baseline data allows healthcare providers to understand a patient’s starting point across glucose control, insulin levels, lipid balance, thyroid function, and organ health. Without this information, it becomes difficult to determine whether future changes reflect treatment response, natural biological variation, or unrelated health shifts.
Monitoring Metabolic and Glycemic Health
This panel is frequently ordered for individuals who are monitoring blood sugar regulation, insulin sensitivity, or cardiometabolic risk over time. GLP-1 pathways are closely tied to glucose metabolism and insulin signaling, making markers such as A1c, eAG, fasting insulin, and lipids especially relevant. Repeating this panel at intervals allows trends to be identified early, even before symptoms appear.
Evaluating Weight and Energy-Related Concerns
Weight regulation involves far more than caloric intake alone. Thyroid activity, insulin resistance, lipid metabolism, and liver function all play meaningful roles. The Basic GLP-1 Blood Test Panel is often ordered when unexplained weight changes, fatigue, or metabolic inefficiency are being evaluated, as it helps identify contributing physiological factors that may influence appetite, energy use, or fat storage.
Supporting Preventive and Long-Term Health Planning
Many individuals and clinicians use this panel proactively, even in the absence of diagnosed disease. Early detection of subtle abnormalities in glucose trends, lipid patterns, or thyroid markers can support preventive strategies and long-term health planning. For patients engaged in lifestyle modifications or structured metabolic programs, this panel provides objective feedback on how the body is responding internally.
What Does the Panel Measure
Complete Blood Count with Differential and Platelets
The CBC evaluates red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. It provides insight into oxygen-carrying capacity, immune system activity, inflammation, and clotting potential. Abnormalities may signal anemia, infection, immune dysfunction, or other systemic issues that can affect overall metabolic health and treatment tolerance.
Comprehensive Metabolic Panel
The CMP measures electrolytes, glucose, calcium, liver enzymes, kidney markers, and protein levels. These markers help assess liver and kidney function, hydration status, and metabolic balance. Because GLP-1–related care can influence appetite and digestion, monitoring organ function is an important safety and optimization step.
Hemoglobin A1c with eAG
Hemoglobin A1c reflects average blood glucose levels over approximately three months, while eAG translates that value into an estimated daily glucose level. These markers are central to assessing long-term glycemic control and identifying patterns that may not be visible through single glucose readings.
Insulin
Fasting insulin provides insight into insulin sensitivity and pancreatic response. Elevated or suppressed insulin levels can help identify insulin resistance or altered metabolic signaling, which are key considerations in GLP-1–related care.
Lipid Panel
The lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. These markers help evaluate cardiovascular risk and metabolic health, both of which are closely tied to glucose regulation and insulin dynamics.
Thyroid-Stimulating Hormone (TSH)
TSH assesses thyroid function, which plays a critical role in metabolism, energy expenditure, and weight regulation. Even subtle thyroid imbalances can influence metabolic outcomes and treatment response.
How Patients and Healthcare Providers Use the Results
Clinical Assessment and Risk Identification
Healthcare providers use the results of the Basic GLP-1 Blood Test Panel to identify patterns consistent with conditions such as insulin resistance, prediabetes, dyslipidemia, metabolic syndrome, thyroid dysfunction, anemia, or early organ stress. While the panel does not diagnose on its own, it provides essential clinical data that informs further evaluation or follow-up testing.
Treatment Planning and Monitoring
For patients undergoing GLP-1–related interventions, these results help guide dosing strategies, safety monitoring, and overall treatment planning. Changes in A1c, insulin, lipids, or metabolic markers over time can indicate how effectively the body is responding and whether adjustments may be needed.
Longitudinal Tracking and Preventive Care
Repeated testing allows both patients and providers to track trends rather than isolated values. Gradual improvements or emerging concerns can be identified early, supporting proactive interventions and informed discussions about lifestyle, nutrition, or additional evaluations.
Patient Education and Engagement
Clear laboratory data helps patients better understand their metabolic health and how different systems in the body interact. This knowledge supports shared decision-making and encourages active participation in long-term health management.
The Basic GLP-1 Blood Test Panel offers a clear, structured view of the key biological systems that influence metabolic health and GLP-1–related care. By combining glucose control, insulin activity, lipid balance, thyroid function, organ health, and blood cell analysis, the panel provides meaningful context that supports informed, responsible monitoring.
Rather than focusing on a single marker, this panel emphasizes the interconnected nature of metabolism. It equips patients and healthcare providers with reliable data to establish baselines, track progress, and interpret changes with confidence. Whether used for initial evaluation, ongoing monitoring, or preventive health planning, the Basic GLP-1 Blood Test Panel serves as a trusted foundation for understanding metabolic health over time.